Synthesis and Antimalarial Evaluation of Halogenated Analogues of Thiaplakortone A
Marine Drugs · 2023
DOI: 10.3390/md21050317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Folake A Egbewande und 4 weiteren Autor:innen. Beteiligte Einrichtung: Griffith Institute for Drug Discovery, School of Environment and Science, Griffith University, Nathan, QLD 4111, Australia. Hauptthemen laut MEDLINE: Antimalarials, Malaria, Falciparum, Biological Products. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Australian Research Council, Medicines for Malaria Venture.
Abstract (Originalsprache)
The incorporation of bromine, iodine or fluorine into the tricyclic core structure of thiaplakortone A (1), a potent antimalarial marine natural product, is reported. Although yields were low, it was possible to synthesise a small nine-membered library using the previously synthesised Boc-protected thiaplakortone A (2) as a scaffold for late-stage functionalisation. The new thiaplakortone A analogues (3–11) were generated using N-bromosuccinimide, N-iodosuccinimide or a Diversinate™ reagent. The chemical structures of all new analogues were fully characterised by 1D/2D NMR, UV, IR and MS data analyses. All compounds were evaluated for their antimalarial activity against Plasmodium falciparum 3D7 (drug-sensitive) and Dd2 (drug-resistant) strains. Incorporation of halogens at positions 2 and 7 of the thiaplakortone A scaffold was shown to reduce antimalarial activity compared to the natural product. Of the new compounds, the mono-brominated analogue (compound 5) displayed the best antimalarial activity with IC50 values of 0.559 and 0.058 μM against P. falciparum 3D7 and Dd2, respectively, with minimal toxicity against a human cell line (HEK293) observed at 80 μM. Of note, the majority of the halogenated compounds showed greater efficacy against the P. falciparum drug-resistant strain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Griffith Institute for Drug Discovery, School of Environment and Science, Griffith University, Nathan, QLD 4111, Australia.
- Discovery Biology, Centre for Cellular Phenomics, Griffith University, Nathan, QLD 4111, Australia.
- NatureBank, Griffith University, Nathan, QLD 4111, Australia.
ORCID-Profile: Vicky M Avery, Rohan A Davis
Förderung
- National Health and Medical Research Council
- Australian Research Council
- Medicines for Malaria Venture
Zitieren
APA
Egbewande, F. A., Schwartz, B. D., Duffy, S., Avery, V. M., & Davis, R. A. (2023). Synthesis and Antimalarial Evaluation of Halogenated Analogues of Thiaplakortone A. Marine Drugs. https://doi.org/10.3390/md21050317
Vancouver
Egbewande FA, Schwartz BD, Duffy S, Avery VM, Davis RA. Synthesis and Antimalarial Evaluation of Halogenated Analogues of Thiaplakortone A. Marine Drugs. 2023. doi:10.3390/md21050317
BibTeX
@article{Egbewande2023,
author = {Egbewande, Folake A and Schwartz, Brett D and Duffy, Sandra and Avery, Vicky M and Davis, Rohan A},
title = {Synthesis and Antimalarial Evaluation of Halogenated Analogues of Thiaplakortone A},
journal = {Marine Drugs},
year = {2023},
doi = {10.3390/md21050317}
}
EUVIMED